Back
ESC2025 Premium Access

Cost-effectiveness of RF RDN in ESC Hypertension guideline-recommended indications in six European countries: an analysis based on Global SYMPLICITY Registry DEFINE data

Session: Renal denervation
Topic: Device Treatment and Intervention
Speaker: Professor R. Schmieder (Erlangen, DE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Roland Schmieder

University Hospital Erlangen, Erlangen (Germany)
27 presentations
0 follower

7 more presentations in this session

Effect of catheter-based renal denervation on orthostatic blood pressure adaptations in patients with uncontrolled hypertension

Speaker: Doctor Z. Zhang (Chengdu, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Renal denervation in hypertensive patients with renal impairment: ultra-long-term follow-up study

Speaker: Doctor L. Wang (Tianjin, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Therapeutic effects of renal denervation beyond arterial hypertension, a systematic review and meta-analysis.

Speaker: Mr A. Makris (Athens, GR)

Access
Abstract
Slides
Video
Like
Thumbnail

Early and sustained blood pressure control from discharge to 12 months after renal denervation: a time in therapeutic range analysis from a nationwide resistant hypertension registry

Speaker: Doctor L. Wu (Hsinchu, TW)

Access
Abstract
Slides
Video
Like
Thumbnail

Long-term outcomes after renal denervation in the two defined ESC guideline-recommended patient groups: an analysis from the Global SYMPLICITY Registry DEFINE

Speaker: Professor F. Mahfoud (Basel, CH)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Renal denervation

Speakers: Professor R. Schmieder, Doctor Z. Zhang, Doctor L. Wang, Mr A. Makris, Doctor L. Wu...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources